These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24100376)

  • 1. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer.
    Arthur JC; Gharaibeh RZ; Uronis JM; Perez-Chanona E; Sha W; Tomkovich S; Mühlbauer M; Fodor AA; Jobin C
    Sci Rep; 2013 Oct; 3():2868. PubMed ID: 24100376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention.
    McFadden RM; Larmonier CB; Shehab KW; Midura-Kiela M; Ramalingam R; Harrison CA; Besselsen DG; Chase JH; Caporaso JG; Jobin C; Ghishan FK; Kiela PR
    Inflamm Bowel Dis; 2015 Nov; 21(11):2483-94. PubMed ID: 26218141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
    Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer.
    Appleyard CB; Cruz ML; Isidro AA; Arthur JC; Jobin C; De Simone C
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1004-13. PubMed ID: 21903764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal inflammation targets cancer-inducing activity of the microbiota.
    Arthur JC; Perez-Chanona E; Mühlbauer M; Tomkovich S; Uronis JM; Fan TJ; Campbell BJ; Abujamel T; Dogan B; Rogers AB; Rhodes JM; Stintzi A; Simpson KW; Hansen JJ; Keku TO; Fodor AA; Jobin C
    Science; 2012 Oct; 338(6103):120-3. PubMed ID: 22903521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.
    Mennigen R; Nolte K; Rijcken E; Utech M; Loeffler B; Senninger N; Bruewer M
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1140-9. PubMed ID: 19221015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer.
    Gao Z; Guo B; Gao R; Zhu Q; Wu W; Qin H
    Mol Med Rep; 2015 Oct; 12(4):6119-27. PubMed ID: 26238090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice.
    Wang CS; Li WB; Wang HY; Ma YM; Zhao XH; Yang H; Qian JM; Li JN
    World J Gastroenterol; 2018 Oct; 24(37):4254-4262. PubMed ID: 30310258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility.
    Uronis JM; Mühlbauer M; Herfarth HH; Rubinas TC; Jones GS; Jobin C
    PLoS One; 2009 Jun; 4(6):e6026. PubMed ID: 19551144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice.
    Mendes MCS; Paulino DS; Brambilla SR; Camargo JA; Persinoti GF; Carvalheira JBC
    World J Gastroenterol; 2018 May; 24(18):1995-2008. PubMed ID: 29760543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis.
    Uronis JM; Arthur JC; Keku T; Fodor A; Carroll IM; Cruz ML; Appleyard CB; Jobin C
    Inflamm Bowel Dis; 2011 Jan; 17(1):289-97. PubMed ID: 20564535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Azoxymethane/Il10
    Rothemich A; Arthur JC
    Methods Mol Biol; 2019; 1960():215-225. PubMed ID: 30798535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.
    Wu M; Wu Y; Deng B; Li J; Cao H; Qu Y; Qian X; Zhong G
    Oncotarget; 2016 Dec; 7(51):85318-85331. PubMed ID: 27863401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications.
    Hörmannsperger G; Clavel T; Hoffmann M; Reiff C; Kelly D; Loh G; Blaut M; Hölzlwimmer G; Haller D
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S10-5. PubMed ID: 20562631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
    Ibrahim A; Hugerth LW; Hases L; Saxena A; Seifert M; Thomas Q; Gustafsson JÅ; Engstrand L; Williams C
    Int J Cancer; 2019 Jun; 144(12):3086-3098. PubMed ID: 30515752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NPC1L1 knockout protects against colitis-associated tumorigenesis in mice.
    He J; Shin H; Wei X; Kadegowda AK; Chen R; Xie SK
    BMC Cancer; 2015 Mar; 15():189. PubMed ID: 25881076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria.
    Bassaganya-Riera J; Viladomiu M; Pedragosa M; De Simone C; Hontecillas R
    PLoS One; 2012; 7(4):e34676. PubMed ID: 22511958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of VSL#3 and
    Meng XC; Wang YN; Yan PG; Li YH; Wang HY; Qian JM; Li JN
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1735-1742. PubMed ID: 31216822
    [No Abstract]   [Full Text] [Related]  

  • 19. Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition.
    Mar JS; Nagalingam NA; Song Y; Onizawa M; Lee JW; Lynch SV
    Gut Microbes; 2014 Jul; 5(4):494-503. PubMed ID: 25144681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice.
    Kumar M; Kissoon-Singh V; Coria AL; Moreau F; Chadee K
    Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G34-G45. PubMed ID: 27856417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.